EMA shortages Medicine discontinued Medicine shortages
Integrilin — supply shortage (medicine discontinued)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Integrilin
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): eptifibatide
- Therapeutic area: Angina, Unstable;Myocardial Infarction
- Pharmaceutical forms affected: Solution for injection;Solution for infusion
- Strengths affected: 2 mg/ml (solution for injection);0.75 mg/ml (solution for infusion)
- Last updated: 03/06/2026
Measures and alternatives
- Availability of alternatives: Yes
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗